Abstract
The last 20 years of the twentieth century witnessed a dramatic increase in research aimed at determining the mechanisms that regulate feeding behavior. Researchers, prompted by the alarming increase in the prevalence of obesity have identified many brain neuropeptides, especially in the hypothalamus that promote or inhibit food intake. How the complex interactions of these peptides leads to obesity has been clarified somewhat; unfortunately, this has not led to major advances in anti-obesity drug discovery. Continued effort during the first years of the new millennium has led to the discovery of new peptides mainly through inverse pharmacology techniques. In this article, we update information on obestatin, a closely related companion of ghrelin, on neuropeptide S, neuropeptide W, and others. These peptides use both classical and independent regulatory pathways to modulate feeding but often have additional biological activities. Strong arguments support a role in feeding regulation for some peptides. For others, this role remains controversial and further research is needed to clarify their exact effects.
Keywords: G-protein coupled receptor, Rfamide, neuromedins, 26Rfa, VGF, QRFP, hypothalamus, obesity
Central Nervous System Agents in Medicinal Chemistry
Title: Neuropeptides B, S and W, Obestatin/Ghrelin-Associated Peptide, and Others: Really New Feeding Regulatory Peptides?
Volume: 8 Issue: 1
Author(s): Bernard Beck, Carine Pourie and Jean-Louis Gueant
Affiliation:
Keywords: G-protein coupled receptor, Rfamide, neuromedins, 26Rfa, VGF, QRFP, hypothalamus, obesity
Abstract: The last 20 years of the twentieth century witnessed a dramatic increase in research aimed at determining the mechanisms that regulate feeding behavior. Researchers, prompted by the alarming increase in the prevalence of obesity have identified many brain neuropeptides, especially in the hypothalamus that promote or inhibit food intake. How the complex interactions of these peptides leads to obesity has been clarified somewhat; unfortunately, this has not led to major advances in anti-obesity drug discovery. Continued effort during the first years of the new millennium has led to the discovery of new peptides mainly through inverse pharmacology techniques. In this article, we update information on obestatin, a closely related companion of ghrelin, on neuropeptide S, neuropeptide W, and others. These peptides use both classical and independent regulatory pathways to modulate feeding but often have additional biological activities. Strong arguments support a role in feeding regulation for some peptides. For others, this role remains controversial and further research is needed to clarify their exact effects.
Export Options
About this article
Cite this article as:
Beck Bernard, Pourie Carine and Gueant Jean-Louis, Neuropeptides B, S and W, Obestatin/Ghrelin-Associated Peptide, and Others: Really New Feeding Regulatory Peptides?, Central Nervous System Agents in Medicinal Chemistry 2008; 8 (1) . https://dx.doi.org/10.2174/187152408783790640
DOI https://dx.doi.org/10.2174/187152408783790640 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Behavioral and Neurochemical Studies in Distinct Animal Models of Ethanols Motivational Effects
Current Drug Abuse Reviews Bioactive N-Phenylimidazole Derivatives
Current Chemical Biology Osteoporosis and its Association with Non-Gonadal Hormones Involved in Hypertension, Adiposity and Hyperglycaemia
Current Drug Targets Chronic Stress and Alzheimers Disease-Like Pathogenesis in a Rat Model: Prevention by Nicotine
Current Neuropharmacology Current Approaches for the Treatment with Thyroid Hormone Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders
Current Neuropharmacology Oleic Acid Protects Against Oxidative Stress Exacerbated by Cytarabine and Doxorubicin in Rat Brain
Anti-Cancer Agents in Medicinal Chemistry Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets The Role of Chromogranins and Other Statins in Homeostasis: An Explanation of the Precise Regulation of Glucose and Ionised Calcium in the Blood; An Overview
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Properties and Pathogenicity of Prion-Derived Peptides
Protein & Peptide Letters Novel Neuropeptides as Ligands of Orphan G Protein-Coupled Receptors
Current Pharmaceutical Design Preclinical Profile of Bacopasides From Bacopa monnieri (BM) As An Emerging Class of Therapeutics for Management of Chronic Pains
Current Medicinal Chemistry Insights Into the Molecular Aspects of Neuroprotective Bacoside A and Bacopaside I
Current Neuropharmacology Ciclesonide - A Novel Corticosteroid for the Management of Asthma
Current Clinical Pharmacology Insulin Resistance and Alzheimers Disease: Molecular Links & Clinical Implications
Current Alzheimer Research Spinal Cord Injury Changes Cytokine Transport
CNS & Neurological Disorders - Drug Targets Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
Current Pharmaceutical Design Pharmacologic Treatment of Rapid Ejaculation: Levels of Evidence-Based Review
Current Clinical Pharmacology The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological Target
Current Neuropharmacology Pathophysiological Mechanisms of Stress-Induced Intestina Damage
Current Molecular Medicine